SCHEDULE: Wellington Management Discloses 5.85% Stake in Heartflow

Wellington Management Group LLP and its affiliates have reported a 5.85% beneficial ownership stake in Heartflow, Inc. common stock.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively reported beneficial ownership of Heartflow, Inc. common stock.
• The aggregate amount beneficially owned by these reporting persons is 4,880,064 shares.
• This ownership represents 5.85% of Heartflow, Inc.'s common stock class.
• The reporting entities hold shared voting power over 4,862,364 shares and shared dispositive power over 4,880,064 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Heartflow, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investment, which generally reflects a positive sentiment from a major asset manager regarding the issuer's value or potential. However, it does not contain performance data or forward-looking statements from the issuer itself.

Positives

• The disclosure of a significant 5.85% stake by a major institutional investor like Wellington Management Group LLP can signal confidence in Heartflow, Inc.'s long-term prospects and business model.
• Increased institutional ownership can lead to greater stock stability and liquidity.

Industry Context

Heartflow, Inc. operates in the medical technology and healthcare sector, focusing on non-invasive cardiac diagnostic solutions. The disclosure of a significant stake by a prominent asset manager like Wellington Management Group LLP is a common occurrence for publicly traded companies, often reflecting institutional interest in the company's market position and growth potential within its industry.

Stakeholder Impact

• Shareholders may view the significant institutional investment as a vote of confidence, potentially leading to increased investor interest and a more stable share price.
• The company's management might perceive this as validation of their strategy and market position.

Key Dates

Keywords

Heartflow, Wellington Management, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, healthcare technology